INM Competitors & Alternatives

Compare InMed Pharmaceuticals Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

INM

Main Stock
$15.56
Tradestie Score
35
Market Cap
$5.29M
Revenue Growth
-0.3%
Analyst Upside
+28.5%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: none
Core Technology Stack: ['biosynthetic cannabinoid production', 'small-molecule formulation']
Major Customers 3
Rare disease clinics Ophthalmology practices Research institutions
Critical Suppliers 3
API manufacturers CROs Cannabinoid precursors
Direct Ecosystem Rivals 1

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$63.93
$543.32M 39.9 33 Compare
TKNO Alpha Teknova, Inc. Common Stock
$8.21
$340.89M - 38 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.83
$237.15M 5.4 35 Compare
CRBP Corbus Pharmaceuticals Holdings, Inc.
$3.39
$159.81M - 41 Compare
SPRC SciSparc Ltd. Ordinary Shares
$0.35
$9.78M 0.0 51 Compare
ENSC Ensysce Biosciences, Inc. Common Stock
$0.42
$7.21M - 67 Compare
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares
$3.70
$4.25M 9.1 44 Compare
REVB Revelation Biosciences, Inc. Common Stock
$4.27
$3.42M - 29 Compare
NUWE Nuwellis, Inc. Common Stock
$4.90
$2.90M 0.0 34 Compare

Data updated: Nov 15, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry